Artelo Biosciences, Inc. executed a 1-for-3 reverse stock split on March 10, 2026, reducing outstanding shares from 2,124,772 to approximately 708,323. The company also adjusted its authorized shares from 500 million to about 166.67 million, while the par value remains $0.001.